Valentina M. Kozlova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Valentina M. Kozlova has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Vera V. Semenova
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
8 shared publications - Tatiana V. Nasedkina
Engelhardt Institute of Molecular Biology
7 shared publications - Svetlana N. Mikhailova
N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia
6 shared publications - Tatiana S. Belysheva
N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia
6 shared publications - Ekaterina E. Zelenova
N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia
5 shared publications - Svetlana R. Varfolomeeva
N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia
5 shared publications
Latest Publications
- 3 April 2026
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 13 (1)
Clinical and genetic features of patients with Li–Fraumeni syndrome: experience of Research Institute of Pediatric Oncology and Hematology named after Academician of the Russian Academy of Medical Sciences L.A. Durnov
Introduction. Li–Fraumeni syndrome (LFS) is associated with a pathogenic variant in the TP53 gene and the development of malignant tumors (MT) in various locations. Moreover, the spectrum of MT is characterized by wide heterogeneity even within a single family. The distribution, type, and position of mutations in the TP53 gene are also variable, and the gene penetrance is incomplete, leading to the presence of healthy carriers of pathogenic variants. Genetic diagnosis of LFS is crucial for the early detection of neoplasms, as well as for the selection of treatment for the primary tumor. The aim of the study was to search for clinical and genetic correlations between pathogenic variants of TP53 and the characteristics of the associated malignant neoplasms (severity of clinical manifestations) for the subsequent classification of patients based on the individual risk of developing MT and the formation of a dynamic observation strategy. Materials and methods . The study included 25 children with confirmed LFS between 2003 and 2025. All patients received treatment at the Pediatric Oncology and Hematology named after Academician of the Russian Academy of Medical Sciences L.A. Durnov. Molecular genetic testing was performed using the next-generation sequencing method using a panel of onco-associated genes. Gene rearrangement analysis was performed using multiplex ligation-dependent probe amplification. Segregation analysis for 30 relatives from 16 families was performed using the Sanger sequencing method. Results. Genetic testing revealed 13 mutations within exons 3–8, as well as the I332Pfs*14 deletion in exon 10 of the TP53 gene. Familial LFS was identified in 13 of 16 families. Penetrance was 75.7 %, with primary multiple tumors identified in 5 (20 %) children and 7 (58 %) patients over 18 years of age. Analysis of pediatric LFS patients allowed us to identify two clinical and genetic groups. The first group of children with highly penetrant pathogenic variants Q165*, R175H, R248W, R273C, R306*, exon 10 deletion, and exon 3 splice site mutation was associated with mesenchymal neoplasms of earlier onset and a high risk of developing second tumors. The second group includes lowpenetrance variants R110C, R196Q, R196P, and S215I, identified in children with aggressive, late-onset, low-risk nervous system tumors. The high-penetrance variant P47R*fs76 was found in one family in children who could be classified into the two aforementioned clinical and genetic groups. Among adult patients, six out of eight women carrying mutations in the TP53 gene were diagnosed with breast cancer, four of them had bilateral tumors. Three patients with bilateral breast cancer and variants G108_F109 del, R175H, and R306* were later diagnosed with MT of other localizations. In men, LFS was manifested by the development of sarcomas after 18 years (P47R*fs76 and R306*), as well as rarer neoplasms such as rectal cancer, lymphoma, and brain tumor (R248W). Conclusion . A genetic study allows not only to confirm the diagnosis of LFS, but also to stratify patients into risk groups for developing certain diseases, which can be used to draw up an individual follow-up plan. Preventive mastectomy may also be considered for women with LFS. Incomplete penetrance and a variety of clinical manifestations indicate the possible influence of modifying factors, which necessitates further investigation of this phenomenon and minimization of contact with carcinogenic factors for carriers of pathogenic variants in the TP53 gene.
- 3 April 2026
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 13 (1)
Clinical and genetic features of patients with Li–Fraumeni syndrome: experience of Research Institute of Pediatric Oncology and Hematology named after Academician of the Russian Academy of Medical Sciences L.A. Durnov
Introduction. Li–Fraumeni syndrome (LFS) is associated with a pathogenic variant in the TP53 gene and the development of malignant tumors (MT) in various locations. Moreover, the spectrum of MT is characterized by wide heterogeneity even within a single family. The distribution, type, and position of mutations in the TP53 gene are also variable, and the gene penetrance is incomplete, leading to the presence of healthy carriers of pathogenic variants. Genetic diagnosis of LFS is crucial for the early detection of neoplasms, as well as for the selection of treatment for the primary tumor. The aim of the study was to search for clinical and genetic correlations between pathogenic variants of TP53 and the characteristics of the associated malignant neoplasms (severity of clinical manifestations) for the subsequent classification of patients based on the individual risk of developing MT and the formation of a dynamic observation strategy. Materials and methods . The study included 25 children with confirmed LFS between 2003 and 2025. All patients received treatment at the Pediatric Oncology and Hematology named after Academician of the Russian Academy of Medical Sciences L.A. Durnov. Molecular genetic testing was performed using the next-generation sequencing method using a panel of onco-associated genes. Gene rearrangement analysis was performed using multiplex ligation-dependent probe amplification. Segregation analysis for 30 relatives from 16 families was performed using the Sanger sequencing method. Results. Genetic testing revealed 13 mutations within exons 3–8, as well as the I332Pfs*14 deletion in exon 10 of the TP53 gene. Familial LFS was identified in 13 of 16 families. Penetrance was 75.7 %, with primary multiple tumors identified in 5 (20 %) children and 7 (58 %) patients over 18 years of age. Analysis of pediatric LFS patients allowed us to identify two clinical and genetic groups. The first group of children with highly penetrant pathogenic variants Q165*, R175H, R248W, R273C, R306*, exon 10 deletion, and exon 3 splice site mutation was associated with mesenchymal neoplasms of earlier onset and a high risk of developing second tumors. The second group includes lowpenetrance variants R110C, R196Q, R196P, and S215I, identified in children with aggressive, late-onset, low-risk nervous system tumors. The high-penetrance variant P47R*fs76 was found in one family in children who could be classified into the two aforementioned clinical and genetic groups. Among adult patients, six out of eight women carrying mutations in the TP53 gene were diagnosed with breast cancer, four of them had bilateral tumors. Three patients with bilateral breast cancer and variants G108_F109 del, R175H, and R306* were later diagnosed with MT of other localizations. In men, LFS was manifested by the development of sarcomas after 18 years (P47R*fs76 and R306*), as well as rarer neoplasms such as rectal cancer, lymphoma, and brain tumor (R248W). Conclusion . A genetic study allows not only to confirm the diagnosis of LFS, but also to stratify patients into risk groups for developing certain diseases, which can be used to draw up an individual follow-up plan. Preventive mastectomy may also be considered for women with LFS. Incomplete penetrance and a variety of clinical manifestations indicate the possible influence of modifying factors, which necessitates further investigation of this phenomenon and minimization of contact with carcinogenic factors for carriers of pathogenic variants in the TP53 gene.
- Open Access
- 31 October 2024
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 11 (3) , 78-86
Bloch–Sulzberger syndrome in the practice of a pediatric oncologist
Bloch–Sulzberger syndrome (SBS, incontinentia pigmenti) is a rare genodermatosis associated with pathogenic variants of the IKBKG (NEMO) gene localized on the long arm of the X chromosome (Xq28). Among the clinical manifestations, the most common are typical stageby-stage skin lesions, the development of ophthalmological and neurological pathology, as well as abnormalities of teeth, hair and nails. Cancer in SBS is extremely rare and known by sporadic cases of retinoblastoma, Wilms tumor, leukemia and skin cancer.We performed clinical and genetic investigation of two families with SBS. In both cases, the deletion of the 4–10 exons of the IKBKG gene was transmitted through the maternal line. In the first case, ophthalmological changes were suspicious of retinoblastoma, but further examination revealed vitreous fibrosis and retinal detachment. In the second case, one of the three sisters was diagnosed with squamous cell skin carcinoma at the age of 11.These clinical observations and the literature review, make necessary to increase the awareness of pediatric oncologists about SBS due to the possible association of this syndrome with an oncogenic risk.
- 31 October 2024
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 11 (3) , 78-86
Open AccessBloch–Sulzberger syndrome in the practice of a pediatric oncologist
Bloch–Sulzberger syndrome (SBS, incontinentia pigmenti) is a rare genodermatosis associated with pathogenic variants of the IKBKG (NEMO) gene localized on the long arm of the X chromosome (Xq28). Among the clinical manifestations, the most common are typical stageby-stage skin lesions, the development of ophthalmological and neurological pathology, as well as abnormalities of teeth, hair and nails. Cancer in SBS is extremely rare and known by sporadic cases of retinoblastoma, Wilms tumor, leukemia and skin cancer.We performed clinical and genetic investigation of two families with SBS. In both cases, the deletion of the 4–10 exons of the IKBKG gene was transmitted through the maternal line. In the first case, ophthalmological changes were suspicious of retinoblastoma, but further examination revealed vitreous fibrosis and retinal detachment. In the second case, one of the three sisters was diagnosed with squamous cell skin carcinoma at the age of 11.These clinical observations and the literature review, make necessary to increase the awareness of pediatric oncologists about SBS due to the possible association of this syndrome with an oncogenic risk.
- Open Access
- 17 January 2024
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 10 (4) , 49-60
Familial DICER1 syndrome with thyroid pathology. A series of clinical cases
Thyroid diseases in childhood occupy the second place after obesity in the structure of the general pathology of the endocrine system, eating disorders and metabolic disorders in children in the Russian Federation. Thyroid cancer in children makes up from 1.5 to 3 % of all malignant tumors, and from 8 to 22 % of malignant solid tumors of the head and neck, and the younger the child’s age, the more aggressive the disease proceeds.Familial forms of thyroid diseases may be associated with geographical features (living in iodine-deficient regions), but may also be part of hereditary syndromes, such as: multiple endocrine neoplasia syndromes (Sipple syndrome, Gorner syndrome, familial medullary thyroid cancer), DICER1 syndrome, Gardner syndrome, Cowden syndrome, McCune–Albright–Braitsev syndrome et al.This article describes several cases of thyroid pathology associated with DICER1 syndrome.
- 17 January 2024
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 10 (4) , 49-60
Open AccessFamilial DICER1 syndrome with thyroid pathology. A series of clinical cases
Thyroid diseases in childhood occupy the second place after obesity in the structure of the general pathology of the endocrine system, eating disorders and metabolic disorders in children in the Russian Federation. Thyroid cancer in children makes up from 1.5 to 3 % of all malignant tumors, and from 8 to 22 % of malignant solid tumors of the head and neck, and the younger the child’s age, the more aggressive the disease proceeds.Familial forms of thyroid diseases may be associated with geographical features (living in iodine-deficient regions), but may also be part of hereditary syndromes, such as: multiple endocrine neoplasia syndromes (Sipple syndrome, Gorner syndrome, familial medullary thyroid cancer), DICER1 syndrome, Gardner syndrome, Cowden syndrome, McCune–Albright–Braitsev syndrome et al.This article describes several cases of thyroid pathology associated with DICER1 syndrome.
- Open Access
- 28 December 2023
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 20 (6) , 557-573
Hereditary syndromes in pediatric hematooncology
Hematooncological diseases head the list in the structure of malignant neoplasms of childhood. Somatic mutations in tumor clone cells have been well studied, included in modern classifications, and are used to stratify patients into prognostic risk groups and select a therapy program. At the same time, more than 50 hereditary syndromes associated with the development of hemoblastoses have been described. Some of them (Down’s syndrome, Klinefelter’s syndrome, microdeletion syndromes et al.) are caused by chromosomal pathology, while others describe alterations of one or more genes with different types of inheritance and age of manifestation of hematooncological diseases. Genes of predisposition to hematooncological diseases are involved in the processes of DNA repair, regulation of the cell cycle, immune response and bone marrow function. This article presents current data on genetic syndromes associated with the development of hemoblastosis with a description of their own clinical observations.
- 28 December 2023
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 20 (6) , 557-573
Open AccessHereditary syndromes in pediatric hematooncology
Hematooncological diseases head the list in the structure of malignant neoplasms of childhood. Somatic mutations in tumor clone cells have been well studied, included in modern classifications, and are used to stratify patients into prognostic risk groups and select a therapy program. At the same time, more than 50 hereditary syndromes associated with the development of hemoblastoses have been described. Some of them (Down’s syndrome, Klinefelter’s syndrome, microdeletion syndromes et al.) are caused by chromosomal pathology, while others describe alterations of one or more genes with different types of inheritance and age of manifestation of hematooncological diseases. Genes of predisposition to hematooncological diseases are involved in the processes of DNA repair, regulation of the cell cycle, immune response and bone marrow function. This article presents current data on genetic syndromes associated with the development of hemoblastosis with a description of their own clinical observations.
- Open Access
- 30 November 2023
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 10 (3) , 89-100
CMMRD-associated embryonic rhabdomyosarcoma in a child. Clinical case with literature review
Introduction. Hereditary disorders in the DNA repair system can lead to the development of malignant neoplasms in childhood. DNA constitutional mismatch repair deficiency syndrome (CMMRD) is a very rare genetic autosomal recessive disorder caused by homozygous mutations in one of the four mismatch repair genes (MLH1, MSH2, MSH6, and PMS2). The frequency of occurrence is 0.0000001 of the adult and child population. For now about 150 observations have been published in the world literature. The prognosis for CMMRD syndrome is extremely unfavorable. The spectrum of tumors that make up the CMMRD syndrome is very wide, and includes mainly malignant brain tumors, tumors of the digestive tract, hematological malignancies, embryonic tumors, all of which develop in childhood.The purpose of the study is to report a case of CMMRD-associated embryonic rhabdomyosarcoma in a 3-year-old child.Conclusions. A review of the literature and the clinical case we have described show that rhabdomyosarcoma belongs to the tumor spectrum of the CMMRD syndrome. An immunohistochemical study revealed an isolated loss of PMS2 gene expression. Taking into account the clinical course of the CMMRD syndrome, a thorough study of the family history in patients with rhabdomyosarcoma is recommended, as well as a molecular genetic study, including the search for germinal mutations in genes in the DNA repair system and the assessment of microsatellite instability in the material of the tumor tissue. The clinical symptoms of CMMRD syndrome are nonspecific and depend on the morphological variant of the primary tumor. Distinctive molecular genetic features of this syndrome are: homozygous mutations with loss of function of the germline genes of the MMR system (mismatch repair) (MLH1, MSH2, MSH6 or PMS2).
- 30 November 2023
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 10 (3) , 89-100
Open AccessCMMRD-associated embryonic rhabdomyosarcoma in a child. Clinical case with literature review
Introduction. Hereditary disorders in the DNA repair system can lead to the development of malignant neoplasms in childhood. DNA constitutional mismatch repair deficiency syndrome (CMMRD) is a very rare genetic autosomal recessive disorder caused by homozygous mutations in one of the four mismatch repair genes (MLH1, MSH2, MSH6, and PMS2). The frequency of occurrence is 0.0000001 of the adult and child population. For now about 150 observations have been published in the world literature. The prognosis for CMMRD syndrome is extremely unfavorable. The spectrum of tumors that make up the CMMRD syndrome is very wide, and includes mainly malignant brain tumors, tumors of the digestive tract, hematological malignancies, embryonic tumors, all of which develop in childhood.The purpose of the study is to report a case of CMMRD-associated embryonic rhabdomyosarcoma in a 3-year-old child.Conclusions. A review of the literature and the clinical case we have described show that rhabdomyosarcoma belongs to the tumor spectrum of the CMMRD syndrome. An immunohistochemical study revealed an isolated loss of PMS2 gene expression. Taking into account the clinical course of the CMMRD syndrome, a thorough study of the family history in patients with rhabdomyosarcoma is recommended, as well as a molecular genetic study, including the search for germinal mutations in genes in the DNA repair system and the assessment of microsatellite instability in the material of the tumor tissue. The clinical symptoms of CMMRD syndrome are nonspecific and depend on the morphological variant of the primary tumor. Distinctive molecular genetic features of this syndrome are: homozygous mutations with loss of function of the germline genes of the MMR system (mismatch repair) (MLH1, MSH2, MSH6 or PMS2).
- Open Access
- 25 August 2023
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 22 (4) , 331-342
Role of Genetic Testing and Complex Endoscopic Examination in Differential Diagnosis of Hereditary Polyposes in Pediatric and Adolescent Patients: 10 Years Clinical Experience
Background. Hereditary polyposis syndromes (HPS) are a group of rare genetic diseases characterized by multiple epithelial lesions in the gastrointestinal tract (GIT) with high risk of malignancy and neoplasia development in other localizations. The case follow-up tactics in hereditary polyposes have significant differences, and differential diagnosis can be complicated due to the phenotype variability and the clinical manifestations similarity. Objective. The aim of the study is to determine the role of molecular genetic testing and endoscopic examination in the diagnosis and management of children with HPS. Materials and methods. The retrospective observational study included 17 patients with clinical signs of hereditary polyposes who applied to the L.A. Durnov Research Institute of Pediatric Oncology and Hematology during the period from 2013 to 2023. All patients underwent molecular genetic testing and comprehensive endoscopic examination of upper and lower GIT. Results. We have divided patients into 7 groups according to the results of genetic testing. Patients had various mutations in genes associated with hereditary tumor syndromes: STK11 (35.3%; n = 6), APC (17.6%; n = 3), PTEN (11.8%; n = 2), SMAD4 (5.9%; n = 1), BMPR1A (5.9%; n = 1), MUTYH (5.9%; n = 1), MLH1 (5.9%; n = 1). One female patient with colorectal cancer with history of adenomatous polyp had pathogenic variants in the ATM and CHEK2 genes; it could be considered as multi-locus tumor syndrome (MINAS) (5.9%, n = 1). Another female patient (5.9%) had multiple gastric body hamartoma polyps and multiple gastric gastrointestinal stromal tumors (GIST) but with no pathogenic mutations. Complex endoscopic examination was performed in 14 (82.3%) patients. Epithelial or non-epithelial lesions of the stomach and intestine were revealed in all cases. Malignant tumors of duodenum and colon were diagnosed in 3 out of 14 patients (21.4%). Morphological variants of these GIT lesions were represented by hamartoma, hyperplastic, and juvenile polyps, adenomas, serrated adenomas, adenocarcinoma, and GIST. The diagnosed epithelial lesions of the stomach, duodenum, and colon were removed via endoscopic polypectomy and endoscopic mucosal resection in 8 out of 14 patients (57.1%). Some cases required small bowel resection (14.3%, n = 2), total colectomy (14.3%, n = 2), and gastrectomy (14.3%, n = 2). Conclusion. Understanding the molecular and biological etiology of HPS, its endoscopic diagnosis, and treatment features allows us to optimize the management of such patients and to minimize the risks of developing malignant tumors in upper and lower GIT, as well as extraintestinal tumors by carrying out timely medical and preventive measures.
- 25 August 2023
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 22 (4) , 331-342
Open AccessRole of Genetic Testing and Complex Endoscopic Examination in Differential Diagnosis of Hereditary Polyposes in Pediatric and Adolescent Patients: 10 Years Clinical Experience
Background. Hereditary polyposis syndromes (HPS) are a group of rare genetic diseases characterized by multiple epithelial lesions in the gastrointestinal tract (GIT) with high risk of malignancy and neoplasia development in other localizations. The case follow-up tactics in hereditary polyposes have significant differences, and differential diagnosis can be complicated due to the phenotype variability and the clinical manifestations similarity. Objective. The aim of the study is to determine the role of molecular genetic testing and endoscopic examination in the diagnosis and management of children with HPS. Materials and methods. The retrospective observational study included 17 patients with clinical signs of hereditary polyposes who applied to the L.A. Durnov Research Institute of Pediatric Oncology and Hematology during the period from 2013 to 2023. All patients underwent molecular genetic testing and comprehensive endoscopic examination of upper and lower GIT. Results. We have divided patients into 7 groups according to the results of genetic testing. Patients had various mutations in genes associated with hereditary tumor syndromes: STK11 (35.3%; n = 6), APC (17.6%; n = 3), PTEN (11.8%; n = 2), SMAD4 (5.9%; n = 1), BMPR1A (5.9%; n = 1), MUTYH (5.9%; n = 1), MLH1 (5.9%; n = 1). One female patient with colorectal cancer with history of adenomatous polyp had pathogenic variants in the ATM and CHEK2 genes; it could be considered as multi-locus tumor syndrome (MINAS) (5.9%, n = 1). Another female patient (5.9%) had multiple gastric body hamartoma polyps and multiple gastric gastrointestinal stromal tumors (GIST) but with no pathogenic mutations. Complex endoscopic examination was performed in 14 (82.3%) patients. Epithelial or non-epithelial lesions of the stomach and intestine were revealed in all cases. Malignant tumors of duodenum and colon were diagnosed in 3 out of 14 patients (21.4%). Morphological variants of these GIT lesions were represented by hamartoma, hyperplastic, and juvenile polyps, adenomas, serrated adenomas, adenocarcinoma, and GIST. The diagnosed epithelial lesions of the stomach, duodenum, and colon were removed via endoscopic polypectomy and endoscopic mucosal resection in 8 out of 14 patients (57.1%). Some cases required small bowel resection (14.3%, n = 2), total colectomy (14.3%, n = 2), and gastrectomy (14.3%, n = 2). Conclusion. Understanding the molecular and biological etiology of HPS, its endoscopic diagnosis, and treatment features allows us to optimize the management of such patients and to minimize the risks of developing malignant tumors in upper and lower GIT, as well as extraintestinal tumors by carrying out timely medical and preventive measures.
- Open Access
- 16 July 2023
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 10 (2) , 34-43
Features of molecular genetic diagnosis of retinoblastoma
Retinoblastoma (RB) is one of the most common malignant neoplasms of the visual organ in children, with an established genetic factor in the development of the disease. The detection of mutations in the RB1 gene has been successfully carried out for many years, however, the development of technologies for DNA diagnostics of RB allows us to consider this disease not only as an independent tumor, but also as one of the manifestations of more complicated genetic syndromes involving a complex of genes. The correct genetic diagnosis is important to understand the prognosis of the health of a patient with RB and recommendations for his further observation, as well as a correct assessment of the risks of having children with the same pathology in the family.Currently available methods of DNA diagnostics of the RB1 gene are new generation sequencing (NGS) and multiplex amplification of ligated probes (MLPA). However, in some cases, additional diagnostics may be required – a karyotype study or chromosomal micromatrix analysis (CMA). In this article we present a molecular genetic study of children with uni- and bilateral RB with an extended deletion at the RB1 gene locus. The aim of the study was determining of possible indications for the appointment of extended DNA diagnostics.
- 16 July 2023
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 10 (2) , 34-43
Open AccessFeatures of molecular genetic diagnosis of retinoblastoma
Retinoblastoma (RB) is one of the most common malignant neoplasms of the visual organ in children, with an established genetic factor in the development of the disease. The detection of mutations in the RB1 gene has been successfully carried out for many years, however, the development of technologies for DNA diagnostics of RB allows us to consider this disease not only as an independent tumor, but also as one of the manifestations of more complicated genetic syndromes involving a complex of genes. The correct genetic diagnosis is important to understand the prognosis of the health of a patient with RB and recommendations for his further observation, as well as a correct assessment of the risks of having children with the same pathology in the family.Currently available methods of DNA diagnostics of the RB1 gene are new generation sequencing (NGS) and multiplex amplification of ligated probes (MLPA). However, in some cases, additional diagnostics may be required – a karyotype study or chromosomal micromatrix analysis (CMA). In this article we present a molecular genetic study of children with uni- and bilateral RB with an extended deletion at the RB1 gene locus. The aim of the study was determining of possible indications for the appointment of extended DNA diagnostics.
- Open Access
- 7 March 2023
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 69 (1) , 30-37
Molecular and genetic aspects of pathogenesis: somatic and germline mutations
Меланома имеет самую высокую мутационную нагрузку среди солидных опухолей. Идентифицировано множество связанных с меланомой соматических и герминальных мутаций в генах, ряд из которых так называемых «драйверных генов», вероятнее всего, включаются в опухолевую прогрессию и являются основными в молекулярной классификации меланомы. В этой части обзора приведен анализ изменений в генах KIT, NF1 RAC1, в зависимости от источника первичной опухоли. Приводятся последние данные о герминальных и соматических мутациях в генах CDKN2A, BAP1, TERT, MITF и др., обнаруженных в меланоме, анализ которых позволяет дополнить знания о причинных механизмах возникновения заболевания.
- 7 March 2023
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 69 (1) , 30-37
Open AccessMolecular and genetic aspects of pathogenesis: somatic and germline mutations
Меланома имеет самую высокую мутационную нагрузку среди солидных опухолей. Идентифицировано множество связанных с меланомой соматических и герминальных мутаций в генах, ряд из которых так называемых «драйверных генов», вероятнее всего, включаются в опухолевую прогрессию и являются основными в молекулярной классификации меланомы. В этой части обзора приведен анализ изменений в генах KIT, NF1 RAC1, в зависимости от источника первичной опухоли. Приводятся последние данные о герминальных и соматических мутациях в генах CDKN2A, BAP1, TERT, MITF и др., обнаруженных в меланоме, анализ которых позволяет дополнить знания о причинных механизмах возникновения заболевания.
- Open Access
- 15 August 2022
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 9 (2) , 60-74
Cancer-associated genodermatoses
Genodermatoses are a heterogeneous group of hereditary diseases that are characterized by predominantly skin lesions. To date, there are more than 200 genetically determined skin diseases, representing about 35 % of all hereditary syndromes. In some cases, skin lesions may be the only manifestation of the disease, but still more often, they occur in combination with disorders of other organ systems. In many cases, genodermatoses are associated with an increased risk of malignancy which makes early detection of hereditary syndromic pathology especially important for cancer prevention.This review provides a brief description of the dermatological manifestations as well as other phenotypic features of a number of genodermatoses, their genetic nature, and the strategy of management.
- 15 August 2022
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 9 (2) , 60-74
Open AccessCancer-associated genodermatoses
Genodermatoses are a heterogeneous group of hereditary diseases that are characterized by predominantly skin lesions. To date, there are more than 200 genetically determined skin diseases, representing about 35 % of all hereditary syndromes. In some cases, skin lesions may be the only manifestation of the disease, but still more often, they occur in combination with disorders of other organ systems. In many cases, genodermatoses are associated with an increased risk of malignancy which makes early detection of hereditary syndromic pathology especially important for cancer prevention.This review provides a brief description of the dermatological manifestations as well as other phenotypic features of a number of genodermatoses, their genetic nature, and the strategy of management.
- Open Access
- 20 January 2022
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 8 (4) , 95-102
Peutz–Jeghers syndrome: a multidisciplinary approach to diagnosis based on a clinical case
Синдром Пейтца–Егерса: мультидисциплинарный подход в диагностике на примере клинического случая
- 20 January 2022
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 8 (4) , 95-102
Open AccessPeutz–Jeghers syndrome: a multidisciplinary approach to diagnosis based on a clinical case
Синдром Пейтца–Егерса: мультидисциплинарный подход в диагностике на примере клинического случая